Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial

Abstract Background To determine the safety and efficacy of different doses of tolvaptan for treating Chinese cirrhotic patients with or without hyponatraemia who still had ascites after routine therapy with diuretics. Methods In the present placebo-controlled, randomized, double-blinded, multicentr...

Full description

Bibliographic Details
Main Authors: Jieting Tang, Yongfeng Wang, Tao Han, Qing Mao, Jun Cheng, Huiguo Ding, Jia Shang, Qin Zhang, Junqi Niu, Feng Ji, Chengwei Chen, Jidong Jia, Xiangjun Jiang, Nonghua Lv, Yueqiu Gao, Zhenghua Wang, Zhong Wei, Yingxuan Chen, Minde Zeng, Yimin Mao
Format: Article
Language:English
Published: BMC 2020-11-01
Series:BMC Gastroenterology
Subjects:
Liver cirrhosis
Cirrhotic patients
Tolvaptan
Ascites
Online Access:http://link.springer.com/article/10.1186/s12876-020-01536-0

Internet

http://link.springer.com/article/10.1186/s12876-020-01536-0

Similar Items